Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. (2023)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/bhbr5832
PubMed Identifier: 37183782
Publication URI: http://europepmc.org/abstract/MED/37183782
Type: Journal Article/Review
Parent Publication: Health technology assessment (Winchester, England)
ISSN: 1366-5278